# Update on Percutaneous Treatment for HFrEF: A Great Armamentarium for a Poor Ventricular Function

## TL;DR

This paper reviews percutaneous treatments for heart failure with reduced ejection fraction, focusing on devices and patient selection criteria.

## Contribution

The paper provides a clinical overview of transcatheter devices for HFrEF, emphasizing selection criteria.

## Key findings

- Percutaneous techniques are available for treating specific heart failure phenotypes.
- Transcatheter devices are part of the interventional cardiologist's armamentarium.
- Clinical and anatomical selection criteria are crucial for patient care.

## Abstract

Pharmacological treatment is the cornerstone therapy of heart failure with
reduced ejection fraction (HFrEF). In addition, several percutaneous techniques
have been developed to treat symptomatic patients, with specific heart failure (HF) phenotypes
(e.g., valvular heart disease) that require non-pharmacological treatment. Given
their prognostic relevance, it is imperative to deliver high-level patient care.
This review provides a clinical overview on the available data regarding
transcatheter devices in the armamentarium of contemporary interventional
cardiologists, focusing on the clinical and anatomical selection criteria.